(Q35542081)

8 August 2017

title

Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin (English)

1 reference

8 August 2017

0 references

1 reference

1 reference

Rybak MJ

1

1 reference

8 August 2017

Frankowski JJ

series ordinal

2

1 reference

8 August 2017

Edwards DJ

series ordinal

3

1 reference

8 August 2017

Albrecht LM

series ordinal

4

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 1987

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

published in

1 reference

8 August 2017

volume

31

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

1461-1464

1 reference

Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Pharmacokinetics of vancomycin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Immunochemical studies of human beta 2-microglobulin. A review of recent methodological progress and clinical applications

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Renal toxicity during therapy with gentamicin or tobramycin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

A prospective study of adverse reactions associated with vancomycin therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Vancomycin enhancement of experimental tobramycin nephrotoxicity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Effects of vancomycin on renal function in rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Immune responses to pneumococcal polysaccharide antigens: a comparison of the murine model and the response in humans.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Clinical Pharmacology of Aminoglycoside Antibiotics in Pediatrics

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174971

Quantitative nephrotoxicity of gentamicin in nontoxic doses

26 September 2018

1 reference

12 December 2020

An optimized assay of alanine aminopeptidase activity in urine

1 reference

12 December 2020

Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum

1 reference

12 December 2020

Aminoglycoside nephrotoxicity and its predictability

1 reference

12 December 2020

Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin

1 reference

12 December 2020

Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks

1 reference

12 December 2020

Animal studies on the reduction of aminoglycoside-induced nephrotoxicity by D-glucaro-1,5-lactam

1 reference

12 December 2020

Additive toxicity in patients receiving vancomycin and aminoglycosides

1 reference

12 December 2020

Renal tolerance and pharmacokinetics of vancomycin in rats

1 reference

12 December 2020

Serum beta 2-microglobulin

1 reference

12 December 2020

Vancomycin. A second look

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.31.10.1461

1 reference

8 August 2017

1 reference

8 August 2017

1 reference